Roivant Sciences

IPOs vs SPACs
IPOs vs SPACs
EP Vantage
IPOs
SPAC
Belite Bio
Cerevel Therapeutics
NewAmsterdam Pharma
Nuvectis Pharma
Oculis
Roivant Sciences
Flag link:
Biotech leader and ex-CEO of Roivant Sciences Ramaswamy may consider running for president as a Republican
Biotech leader and ex-CEO of Roivant Sciences Ramaswamy may consider running for president as a Republican
Politico
2024 Presidential election
Vivek Ramaswamy
Roivant Sciences
Flag link:
Roivant’s Matt Gline on the hub-and-spoke biotech model and lessons learned from Axovant
Roivant’s Matt Gline on the hub-and-spoke biotech model and lessons learned from Axovant
Biopharma Dive
Roivant Sciences
IBD
Pfizer
Matt Gline
hub-and-spoke
Flag link:
Fresh from Pfizer deal, Roivant posts 'best-in-class' ulcerative colitis data on rival to Prometheus prospect
Fresh from Pfizer deal, Roivant posts 'best-in-class' ulcerative colitis data on rival to Prometheus prospect
Fierce Biotech
Roivant Sciences
ulcerative colitis
clinical trials
RVT-3101
Flag link:
Roivant decants another Vant armed with Eisai blood cancer drug and plans to start phase 1/2 soon
Roivant decants another Vant armed with Eisai blood cancer drug and plans to start phase 1/2 soon
Fierce Biotech
Hemavant
Roivant Sciences
Eisai
MDS
RVT-2001
Flag link:
Immunovant Shares Drop After Roivant Opts for Strategic Investment
Immunovant Shares Drop After Roivant Opts for Strategic Investment
Marketwatch
Immuovant
Roivant Sciences
Flag link:
Roivant’s move to go public reveals just how much its drug strategy has changed
Roivant’s move to go public reveals just how much its drug strategy has changed
MedCity News
Roivant Sciences
Vivek Ramaswamy
Flag link: